We are live on ! Find out more

Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
CNC icon
51
Centene
CNC
$31.9B
$31.9B $64.50 1.16%
GEHC icon
52
GE HealthCare
GEHC
$31.6B
$31.6B $70.06 0.47%
BIIB icon
53
Biogen
BIIB
$30.7B
$30.7B $207.47 2.8%
ILMN icon
54
Illumina
ILMN
$30.2B
$30.2B $199.72 0.79%
ALNY icon
55
Alnylam Pharmaceuticals
ALNY
$29.2B
$29.2B $218.20 0.97%
MTD icon
56
Mettler-Toledo International
MTD
$28.8B
$28.8B $1,435.44 0.66%
PHG icon
57
Philips
PHG
$25.9B
$25.9B $26.47 0.91%
DGX icon
58
Quest Diagnostics
DGX
$25.8B
$25.8B $233.95 0.86%
RPRX icon
59
Royalty Pharma
RPRX
$25.5B
$25.5B $57.48 0.54%
LH icon
60
Labcorp
LH
$25.2B
$25.2B $311.26 1.25%
ROIV icon
61
Roivant Sciences
ROIV
$24.9B
$24.9B $34.44 3.36%
WST icon
62
West Pharmaceutical
WST
$24.4B
$24.4B $347.34 0.17%
INCY icon
63
Incyte
INCY
$24.4B
$24.4B $120.14 1.44%
BNTX icon
64
BioNTech
BNTX
$23.1B
$23.1B $91.29 1.04%
MRNA icon
65
Moderna
MRNA
$22.8B
$22.8B $57.14 3.63%
STE icon
66
Steris
STE
$22.6B
$22.6B $232.19 0.19%
UTHR icon
67
United Therapeutics
UTHR
$21.9B
$21.9B $515.98 0.06%
GH icon
68
Guardant Health
GH
$21.5B
$21.5B $159.88 0.66%
INSM icon
69
Insmed
INSM
$21.4B
$21.4B $98.83 0.39%
VTRS icon
70
Viatris
VTRS
$20.6B
$20.6B $17.66 0.17%
THC icon
71
Tenet Healthcare
THC
$20.4B
$20.4B $253.07 1.23%
ZBH icon
72
Zimmer Biomet
ZBH
$18.6B
$18.6B $95.96 1.05%
GMAB icon
73
Genmab
GMAB
$17.8B
$17.8B $29.05 1.29%
NBIX icon
74
Neurocrine Biosciences
NBIX
$17B
$17B $167.31 0.65%
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$16.3B
$16.3B $259.50 3.15%
1 2
3
4 5

Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 1,066 Healthcare sector stocks tracked by Wall St. Rank, worth a combined $8.93T.

The largest by market cap are Eli Lilly (LLY) at $998B, Johnson & Johnson (JNJ) at $612B and AbbVie (ABBV) at $429B.

Among institutional investors, Waters Corp (WAT) drew the most net new fund positions in Q1 2026: 461 funds opened new positions, taking total fund holders up 365 (45%) quarter-over-quarter.

  • Combined market cap: $8.93T across 1,066 stocks.
  • Largest constituent: Eli Lilly (LLY), $998B market cap.
  • Most net new fund positions in Q1 2026: Waters Corp (WAT), +365 holders.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.